At Chr. Hansen, we have over 100 years of expertise in the development of probiotics for the human microbiome. Our probiotic strains are some of the world’s most documented, providing a range of health benefits in people of all ages, ranging from pre-term babies to the elderly. All of our strains are backed by science, supported by clinical research and are safe to consume. Learn more about how Chr. Hansen probiotic strains can positively influence different areas of human health.
Your health -
Lactobacillus rhamnosus, LGG® is the world’s most documented probiotic strain. The LGG® strain has proven benefits across all ages and numerous health areas, including gastrointestinal, immune and oral health.
LGG® is a trademark of Chr. Hansen A/S
The probiotic strain Bifidobacterium, BB-12® is the world’s most documented probiotic Bifidobacterium. It has been extensively studied and has been associated with improved outcomes across various areas of health.
BB-12® is a trademark of Chr. Hansen A/S
The probiotic strain Bifidobacterium infantis (DSM 33361) has been studied in preterm infants in several clinical trials. It is a promising infant strain as it has the right characteristics to support healthy infant gut development.
The probiotic strain Lactobacillus paracasei, L. CASEI 431® has demonstrated improvements to immune health in high-quality, human clinical studies.
L. CASEI 431® is a trademark of Chr. Hansen A/S
The UREX™ blend is a combination of two probiotic bacterial strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®. UREX™ has been associated with supporting female urogenital health.
UREX™, GR-1® and RC-14® are trademarks of Chr. Hansen A/S
The probiotic strain Lactobacillus acidophilus, LA-5® has demonstrated benefits, for example, in gastrointestinal health when used in combination with Bifidobacterium, BB-12®.
LA-5® and BB-12® are trademarks of Chr. Hansen A/S